ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
NASDAQ:ATAI
Price:
4.345
USD
-0.57%
Market Closed
Market Cap:
$1.6B
Cash Flow Statement
Cash Flow Statement
ATAI Life Sciences NV
ATAI Life Sciences NV
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(227)
|
(175)
|
(174)
|
(212)
|
(200)
|
(204)
|
(157)
|
(154)
|
(150)
|
(71)
|
(44)
|
(37)
|
(61)
|
(130)
|
(150)
|
(149)
|
(120)
|
(154)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
105
|
115
|
63
|
74
|
45
|
44
|
42
|
41
|
40
|
38
|
33
|
30
|
28
|
24
|
25
|
23
|
19
|
18
|
|
| Other Non-Cash Items |
200
|
130
|
119
|
134
|
109
|
108
|
51
|
46
|
42
|
(27)
|
(48)
|
(48)
|
(20)
|
52
|
76
|
77
|
44
|
73
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
3
|
2
|
0
|
1
|
(1)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
2
|
3
|
2
|
4
|
2
|
2
|
3
|
1
|
|
| Change in Working Capital |
1
|
(4)
|
(8)
|
(9)
|
(4)
|
1
|
(3)
|
2
|
0
|
1
|
7
|
(1)
|
1
|
(3)
|
(9)
|
(6)
|
(1)
|
1
|
|
| Cash from Operating Activities |
(26)
N/A
|
(49)
-86%
|
(63)
-29%
|
(87)
-38%
|
(95)
-8%
|
(94)
+0%
|
(104)
-11%
|
(102)
+3%
|
(102)
-1%
|
(93)
+9%
|
(84)
+9%
|
(86)
-2%
|
(79)
+7%
|
(80)
-1%
|
(82)
-3%
|
(78)
+6%
|
(76)
+3%
|
(79)
-5%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(5)
|
(5)
|
(11)
|
|
| Other Items |
(41)
|
(36)
|
(80)
|
(295)
|
(281)
|
(214)
|
(86)
|
145
|
141
|
28
|
(53)
|
(58)
|
(20)
|
52
|
59
|
42
|
36
|
(51)
|
|
| Cash from Investing Activities |
(41)
N/A
|
(37)
+12%
|
(81)
-123%
|
(296)
-264%
|
(282)
+5%
|
(216)
+24%
|
(87)
+60%
|
144
N/A
|
140
-3%
|
28
-80%
|
(53)
N/A
|
(58)
-9%
|
(20)
+66%
|
52
N/A
|
59
+14%
|
37
-38%
|
30
-18%
|
(62)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
493
|
493
|
411
|
411
|
2
|
4
|
3
|
3
|
2
|
0
|
0
|
(0)
|
0
|
0
|
1
|
61
|
92
|
149
|
|
| Net Issuance of Debt |
21
|
9
|
8
|
8
|
8
|
20
|
20
|
0
|
19
|
0
|
0
|
0
|
0
|
5
|
5
|
0
|
0
|
0
|
|
| Other |
(10)
|
(12)
|
(10)
|
(10)
|
(2)
|
(1)
|
(2)
|
0
|
(2)
|
(1)
|
(9)
|
0
|
(8)
|
(9)
|
(0)
|
(1)
|
(24)
|
(22)
|
|
| Cash from Financing Activities |
504
N/A
|
490
-3%
|
410
-16%
|
410
+0%
|
8
-98%
|
23
+211%
|
21
-11%
|
21
+0%
|
19
-9%
|
(1)
N/A
|
(8)
-931%
|
(9)
-3%
|
(8)
+5%
|
(3)
+60%
|
5
N/A
|
65
+1 109%
|
72
+11%
|
127
+76%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
2
|
3
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
1
|
(0)
|
|
| Net Change in Cash |
439
N/A
|
408
-7%
|
265
-35%
|
27
-90%
|
(369)
N/A
|
(288)
+22%
|
(172)
+40%
|
62
N/A
|
57
-8%
|
(66)
N/A
|
(146)
-120%
|
(152)
-4%
|
(107)
+30%
|
(32)
+70%
|
(18)
+44%
|
24
N/A
|
28
+13%
|
(15)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(27)
N/A
|
(50)
-86%
|
(64)
-29%
|
(88)
-37%
|
(95)
-8%
|
(96)
0%
|
(105)
-10%
|
(103)
+2%
|
(104)
-1%
|
(93)
+10%
|
(85)
+9%
|
(86)
-1%
|
(79)
+8%
|
(80)
-1%
|
(83)
-3%
|
(83)
-1%
|
(81)
+2%
|
(90)
-11%
|
|
Switch to:
Switch to:
See Also
Discover More
